(Q37928906)

25 August 2017

1 reference

title

Chronic kidney disease in postmenopausal women (English)

1 reference

chronic renal insufficiency

25 August 2017

main subject

1 reference

Hiromichi Suzuki

1

1 reference

25 August 2017

Kazuoki Kondo

series ordinal

2

1 reference

25 August 2017

publication date

8 September 2011

1 reference

25 August 2017

published in

Hypertension Research

1 reference

25 August 2017

volume

35

1 reference

25 August 2017

issue

2

1 reference

25 August 2017

page(s)

142-147

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2011.155

25 August 2017

exact match

0 references

cites work

Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Menopausal status influences ambulatory blood pressure levels and blood pressure changes during mental stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Risk assessment and treatment benefit in intensively treated hypertensive patients of the hypertension Optimal Treatment (HOT) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Kidney disease as an independent risk factor for cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Renal function predicts cardiovascular outcomes in southern Italian postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Progress in osteoporosis and fracture prevention: focus on postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Serum malondialdehyde and coronary artery disease in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Cardiovascular disease in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Sex steroids, cardiovascular disease, and hypertension: unanswered questions and some speculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Gender and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Female sex hormones, salt, and blood pressure regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Role of the gonads in hypertension-prone rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Blunted pressure natriuresis in ovariectomized Dahl-Iwai salt-sensitive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Postovariectomy hypertension is linked to increased renal AT1 receptor and salt sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

The protective effects of estrogen on the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Estrogen modulates AT1 receptor gene expression in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Sex hormones and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Estrogen reduces angiotensin II-induced nitric oxide synthase and NAD(P)H oxidase expression in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Salt sensitivity and hypertension after menopause: role of nitric oxide and angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Divergent effects of estrogen and nicotine on Rho-kinase expression in human coronary vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Transcription factor cross-talk: the estrogen receptor and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

17beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Estrogen and angiotensin II interactions determine cardio-renal damage in Dahl salt-sensitive rats with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Estradiol upregulates mesangial cell MMP-2 activity via the transcription factor AP-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Differential effects of continuous and intermittent 17beta-estradiol replacement and tamoxifen therapy on the prevention of glomerulosclerosis: modulation of the mesangial cell phenotype in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Novel mechanisms responsible for postmenopausal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Death rates from ischemic heart disease in women with a history of hypertension in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Estrogen modulation of endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Insulin resistance and sympathetic overactivity in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Short- and long-term prognosis of blood pressure and kidney disease in women with a past history of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Metabolic syndrome after menopause and the role of hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Multifactorial determination of hypertensive nephroangiosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Postmenopausal hormone replacement improves proteinuria and impaired creatinine clearance in type 2 diabetes mellitus and hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Management of peripheral arterial disease in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Creatinine levels and cardiovascular events in women with heart disease: do small changes matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Kidney dysfunction and sudden cardiac death among women with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Testosterone supplementation in aging men and women: possible impact on cardiovascular-renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Regulation of ion channels by secreted Klotho: mechanisms and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Osteoporosis in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Microalbuminuria in patients with essential hypertension: effects of several antihypertensive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Association of kidney function with incident hip fracture in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Chronic kidney disease and bone fracture: a growing concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Renal function and risk of hip and vertebral fractures in older women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

The effect of postmenopausal estrogen therapy on bone density in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

The effect of raloxifene treatment in postmenopausal women with CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Osteoporosis and chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Raloxifene decreases serum malondialdehyde and nitric oxide levels in postmenopausal women with end-stage renal disease under chronic hemodialysis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Exploring the biology of vascular calcification in chronic kidney disease: what's circulating?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Alendronate Treatment in Women With Normal to Severely Impaired Renal Function: An Analysis of the Fracture Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Hyperparathyroidism and 1,25-Dihydroxyvitamin D Deficiency in Mild, Moderate, and Severe Renal Failure*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

Adiponectin and Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

7 January 2021

Cross-talk between the kidney and the cardiovascular system

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

7 January 2021

Oxidative status and prevalent cardiovascular disease in patients with chronic renal failure treated by hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

7 January 2021

Hypertension in postmenopausal women: pathophysiology and management.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

7 January 2021

Different associations of blood pressure with 24-hour urinary sodium excretion among pre- and post-menopausal women. WHO Cardiovascular Diseases and Alimentary Comparison (WHO-CARDIAC) Study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

7 January 2021

Estrogen regulation of angiotensin-converting enzyme mRNA

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

7 January 2021

Selective estrogen receptor modulators suppress mesangial cell collagen synthesis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

7 January 2021

Effects of estrogen replacement therapy on the lipoprotein profile in postmenopausal women with ESRD

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

7 January 2021

National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

7 January 2021

Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

7 January 2021

Risk factors for hip fracture among patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

7 January 2021

Increased risk of hip fracture among patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

7 January 2021

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

7 January 2021

The benefits of hormone replacement therapy in pre-menopausal women with oestrogen deficiency on haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

7 January 2021

Mechanisms of vascular calcification in renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.155

7 January 2021

Identifiers

DOI

10.1038/HR.2011.155

1 reference

Dimensions Publication ID

25 August 2017

1046306898

0 references

1 reference